Clinical trial
Study on the Immunogenicity and Safety of Inactivated Enterovirus Type 71 Vaccine Combined Administration With Recombinant Hepatitis B and Group A Meningococcal Vaccine
NCT06209398 is registered in ClinicalTrials.gov with Jiangsu Province Centers for Disease Control and Prevention as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Study on the Immunogenicity and Safety of Inactivated Enterovirus Type 71 Vaccine Combined Administration With Recombinant Hepatitis B and Group A Meningococcal Vaccine
- Lead sponsor
- Jiangsu Province Centers for Disease Control and Prevention
- Phase
- Phase 4
- Overall status
- Unknown status
- Start date
- May 24, 2018
- Completion date
- December 31, 2025
- Enrollment
- 510 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.